Next report date
Report period
Q1 2024
EPS estimate
−0.21USD
Revenue estimate
6.36 MUSD
−257.83 MUSD
176.23 MUSD
183.15 M
Om Sangamo Therapeutics, Inc.
Sektor
Bransch
VD
Alexander D. Macrae
Webbplats
Huvudkvarter
Richmond
Employees (FY)
405
Grundat
1995
FIGI
BBG000BHYT80
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
